v3.25.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2025
STOCKHOLDERS' EQUITY  
Schedule of designation, shares authorized, and shares outstanding for the Company's Preferred Stock

Preferred Shares

Preferred Shares

Potentially Issuable

Preferred Stock Series Designation

    

Authorized

    

Outstanding

    

Preferred Shares

Series Seed

213,000,000

204,810,720

8,189,280

Series A

207,000,000

185,440,880

21,559,120

Series T

99,000,000

9,642,080

89,357,920

Schedule of inputs valued under using the Black-Scholes pricing model

    

2025

 

Expected life (years)

 

6.5

Risk-free interest rate

 

4.0 -4.6

%

Expected volatility

 

39.5 - 45.7

%

Annual dividend yield

 

0

%

Schedule of stock option activity and related information

Options

   

Weighted- Average Exercise Price

   

Aggregate Intrinsic Value

Outstanding at December 31, 2024

183,131,478

0.20

-

Granted

12,150,000

1.25

-

Exercised

(18,242,157)

0.01

-

Forfeited

(3,190,000)

1.05

-

Expired

-

-

-

Outstanding at June 30, 2025

173,849,321

0.30

-

Exercisable at June 30, 2025

81,930,210

0.54

-

Schedule of stock option expense

    

2025

    

2024

Cost of revenues

$

600,068

$

666,149

General and administrative

 

968,289

 

671,712

Sales and marketing

 

2,684,036

 

2,705,426

Research and development

 

925,122

 

1,276,627

Total

$

5,177,515

$

5,319,914